LATEST ALERTS
Cristine Delnevo, the new chair of the US FDA’s Tobacco Products Scientific Advisory Committee (TPSAC), has been hailed as an “objective, thoughtful scientist” with an understanding of research into harm reduction
While nicotine pouches are classed in the EU as food products with an unauthorised ingredient, it could be argued that there is nothing novel about tobacco, or nicotine, in food – and it could have an important future too
While nicotine pouches are growing in popularity fast, the state of science on their safety remains threadbare
Scientific research into novel nicotine alternatives has so far largely focused on vaping, but that is likely to change as the products become more widespread
Public health in the north of England continues to be ignored in favour of supporting more affluent and Tory-leaning areas in the south and Midlands, according to a new survey
The author of a new study linking snus with smoking cessation has called on the World Health Organization “to move from rejecting tobacco harm reduction to promoting it”
Innovation in nicotine pouches – better release profile, longer lasting flavour and effect – is coming from an unexpected area… the remarkable world of concrete
Recognition of the role vaping can play in the future of public health in England has been welcomed – but there is some disappointment that the positive approach does not extend to other alternatives to smoking
On international World No Tobacco Day tobacco alternatives such as pouches were not excluded from the criticisms
Next-generation tobacco products are not the solution to damage caused by the tobacco industry to both public health and the environment, according to speakers at a World Health Organization (WHO) conference
Most tobacco companies are keen to be seen supporting the concept of harm reduction, especially through reduced-risk products like e-cigarettes, heat-not-burn and pouches. But how far is their support for the idea actually having an effect on their activities right now, as well as their future direction?
The World Health Organization (WHO)’s rejection of a new Covid-19 vaccine on anti-tobacco grounds will almost certainly end up having a negative impact on public health – particularly in the developing world
Speaking at the launch of the seventh edition of the Atlas, US public health scholar Jeffrey Drope suggested that new nicotine technologies are “a huge distraction” which have “confused governments, the public health community and the public”
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Get 7 days of FREE platform access: Demo our data contents without commitment
"*" indicates required fields
